Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “TOCILIZUMAB”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03699631
What this trial is testing

PROACTIVE: Preventing Acute/Chronic GVHD With TocIlizumab Combined With GVHD Prophylaxis Post allogEneic Transplant

Who this might be right for
Hematologic Malignancy
Medical College of Wisconsin 29
Large-scale testing (Phase 3)Study completedNCT05489224
What this trial is testing

Compare Efficacy and Safety of CT-P47 and RoActemra in Patients With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Celltrion 471
Large-scale testing (Phase 3)Ended earlyNCT01209689
What this trial is testing

Tocilizumab (RoActemra/Actemra) in Patients With Ankylosing Spondylitis Who Have Had an Inadequate Response to Previous Tumor Necrosis Factor (TNF) Antagonist Therapy

Who this might be right for
Spondylitis, Ankylosing
Hoffmann-La Roche 113
Not applicableStudy completedNCT01667458
What this trial is testing

An Observational Study on Fatigue in Patients With Rheumatoid Arthritis Treated With RoActemra/Actemra (Tocilizumab)

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 59
Not applicableStudy completedNCT04519385
What this trial is testing

Toclizumam Versus Dexamethasone in Severe Covid-19 Cases

Who this might be right for
Pneumonia, Viral
South Valley University 69
Early research (Phase 1)Study completedNCT01418989
What this trial is testing

Administration of RoActemra/Actemra (Tocilizumab) by Auto-injector Vs. Pre-filled Syringe in Healthy Volunteers

Who this might be right for
Healthy Volunteer
Hoffmann-La Roche 239
Large-scale testing (Phase 3)Study completedNCT01610791
What this trial is testing

RoActemra/Actemra (Tocilizumab) in Patients With Active Rheumatoid Arthritis Who Have an Inadequate Response to DMARDs (REMISSION)

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 121
Post-approval studies (Phase 4)UnknownNCT02087696
What this trial is testing

Uncontrolled Study to Evaluate Efficacy of Tocilizumab in Patients With Moderate or Severe Rheumatoid Arthritis

Who this might be right for
Arthritis, Rheumatoid
Spanish Foundation of Rheumatology 122
Large-scale testing (Phase 3)Study completedNCT00642460
What this trial is testing

RoActemra/Actemra (Tocilizumab) in Patients With Active Systemic Juvenile Idiopathic Arthritis (JIA)

Who this might be right for
Juvenile Idiopathic Arthritis
Hoffmann-La Roche 112
Not applicableStudy completedNCT04734678
What this trial is testing

Comparison of Tocilizumab Versus Tocilizumab/Infliximab in Patients With COVID-19-associated Cytokine Storm Syndrome

Who this might be right for
Covid19Cytokine StormCorona Virus Infection
Ain Shams University 153
Post-approval studies (Phase 4)UnknownNCT03895879
What this trial is testing

Use of Tocilizumab Drug Levels to Optimize Treatment in RA

Who this might be right for
Rheumatoid Arthritis
Reade Rheumatology Research Institute 98
Large-scale testing (Phase 3)Study completedNCT01782235
What this trial is testing

Efficacy of Tocilizumab in Primary Sjögren's Syndrome.

Who this might be right for
Primary Sjögren's Syndrome (pSS)
University Hospital, Strasbourg, France 110
Large-scale testing (Phase 3)Study completedNCT01855789
What this trial is testing

The Impact of Methotrexate (MTX) Discontinuation on the Efficacy of Subcutaneous (SC) Tocilizumab (TCZ) With MTX

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 718
Testing effectiveness (Phase 2)Study completedNCT01441063
What this trial is testing

Tocilizumab for KSHV-Associated Multicentric Castleman Disease

Who this might be right for
Castleman DiseaseMulticentric Castleman DiseaseGiant Lymph Node Hyperplasia
National Cancer Institute (NCI) 8
Post-approval studies (Phase 4)Study completedNCT01557374
What this trial is testing

TOward the Lowest Effective DOse of Abatacept or Tocilizumab

Who this might be right for
Rheumatoid Arthritis
Assistance Publique - Hôpitaux de Paris 232
Post-approval studies (Phase 4)WithdrawnNCT01878318
What this trial is testing

The Effect of RoActemra/Actemra (Tocilizumab) in Combination With Methotrexate on Articular Damage in The Hand in Patients With Moderate to Severe Rheumatoid Arthritis Who Have an Inadequate Response to Non-Biological DMARDs

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche
Testing effectiveness (Phase 2)UnknownNCT05181397
What this trial is testing

The Efficacy and Safety of Tocilizumab for Severe RP-ILD Secondary to Systemic Diseases

Who this might be right for
Rapid Progressive Interstitial Lung Diseases
Peking Union Medical College Hospital 68
Large-scale testing (Phase 3)UnknownNCT04345445
What this trial is testing

Study to Evaluate the Efficacy and Safety of Tocilizumab Versus Corticosteroids in Hospitalised COVID-19 Patients With High Risk of Progression

Who this might be right for
COVID-19
University of Malaya 310
Large-scale testing (Phase 3)Study completedNCT01730456
What this trial is testing

A Long-Term Extension Study of RoActemra/Actemra (Tocilizumab) in Patients With Early Moderate to Severe Rheumatoid Arthritis Who Completed Study WA19926

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 13
Not applicableStudy completedNCT07459335
What this trial is testing

TArget Trial Emulation Comparing Effectiveness of Tocilizumab vs Methotrexate In Corticosteroid-Treated GCA Patients

Who this might be right for
Giant Cell Arteritis (GCA)Cardiovascular Diseases
Groupe français d'étude des Maladies Inflammatoires de loeil 1,667
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation